Thomas J Moore

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

BMJ open

Pharmaceutical medicine

Annals of internal medicine

Pharmacotherapy

Drug Safety Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Drug Safety Research

United States

Principal

Institute for Safe Medication Practices

United States

Senior Scientist

Publications

Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Phillip W Wirtz, Jill N Curran, G Caleb Alexander
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis. BMJ open 13 (4) (2023)
Thomas J Moore, Abdallah Alami, G Caleb Alexander, Donald R Mattison
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review. Pharmacotherapy 42 (7) (2022)
Thomas J Moore, Richard L Morrow, Colin R Dormuth, Barbara Mintzes
US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS). Pharmaceutical medicine 34 (2) (2021)
Thomas J Moore, Phillip W Wirtz, Stefan P Kruszewski, G Caleb Alexander
Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study. BMJ open 11 (8) (2021)
Hemalkumar B Mehta, Stephan Ehrhardt, Thomas J Moore, Jodi B Segal, G Caleb Alexander
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis. BMJ open 10 (6) (2020)
Thomas J Moore, James Heyward, Gerard Anderson, G Caleb Alexander
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015-2017: a cross-sectional study. BMJ open 10 (6) (2020)
James Heyward, Thomas J Moore, Jennifer Chen, Kristin Meek, Peter Lurie, G Caleb Alexander
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018. Annals of internal medicine 173 (12) (2020)

Thomas J Moore.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas J Moore